RSNA 2019 News

FDA clears XACT Robotics' interventional system

By staff writers
October 31, 2019

The U.S. Food and Drug Administration (FDA) has cleared XACT Robotics' robotics system for CT-guided percutaneous interventional procedures.

XACT Robotics System is a hands-free device that allows users to plan and navigate procedures using imaging. It was developed at the Technion-Israel Institute of Technology in Haifa, Israel, by Moshe Shoham, DSc, founder of Mazor Robotics.

XACT Robotics plans to debut the system at the upcoming RSNA 2019 meeting, the company said.

Copyright © 2019

Last Updated np 10/31/2019 1:47:34 PM